Literary evidence of the impact of nonbiological risk factors on CRMS/CFSPID: A scoping review
Authors:
- 21 August 2024
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 59 (12) , 3095-3105
Abstract
Newborn screening for cystic fibrosis (CF) occasionally results in an inconclusive diagnosis of this disease, and these individuals are designated as CFTR‐related metabolic syndrome (CRMS) in the United States, and CF Screen Positive Inconclusive Diagnosis (CFSPID) in other countries. Some of these asymptomatic individuals will progress to symptomatic disease, but risk factors associated with disease progression are not well understood. This scoping review was conducted to comprehensively map nonbiological risk factors in the CRMS/CFSPID literature and to identify understudied topics. Six electronic databases were systematically searched, resulting in 2951 studies. Forty nine eligible works were identified as including information on nonbiological risk factors related to CRMS/CFPSID. Eligible studies were published from 2002 to 2024, most prevalently in the United States (36.7%), and as quantitative data (81.6%). Of the 49 eligible works, 23 articles contributed only intellectual conjecture, while 26 articles contained original data, which underwent full‐text qualitative content analysis. Key themes identified in descending order of content coverage included Psychological Impact , Management Care , Newborn Screening and Diagnostics , Communicating Diagnosis , and Lifestyle and External Exposures . This scoping review identified that while nonbiological risk factors are being studied in the CRMS/CFSPID literature, there was nearly equal distribution of works gathering original data to those citing previously published information. These findings indicate a critical need for original data collection on these risk factors, particularly on understudied topics identified herein.Keywords
Funding Information
- Cystic Fibrosis Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
This publication has 84 references indexed in Scilit:
- Built environment factors predictive of early rapid lung function decline in cystic fibrosisPediatric Pulmonology, 2023
- Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassificationPediatric Pulmonology, 2023
- Refinement of newborn screening for cystic fibrosis with next generation sequencingPediatric Pulmonology, 2022
- β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?Pediatric Pulmonology, 2022
- Real-world Associations of US Cystic Fibrosis Newborn Screening Programs With Nutritional and Pulmonary OutcomesJAMA Pediatrics, 2022
- Social determinants of health screening and intervention: A cystic fibrosis quality improvement processPediatric Pulmonology, 2022
- Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelinesPediatric Pulmonology, 2021
- Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screeningPediatric Pulmonology, 2020
- Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen‐positive diagnostic resolution processJournal of Genetic Counseling, 2019
- Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screeningPediatric Pulmonology, 2015